Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
International Journal of Hematology
|
April 4, 2000
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors
K Takeyama, M Seto, N Uike, et al.
Blood
|
March 25, 2000
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
Y Yatabe, R Suzuki, K Tobinai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
R Seki, K Ohshima, T Fujisaki, et al.
Leukemia & Lymphoma
|
August 23, 2000
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study Group
K Itoh, T Ohtsu, Y Sasaki, et al.
International Journal of Hematology
|
October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis
T Okamoto, A Kanamaru, C Shimazaki, et al.
Journal of Gastroenterology and Hepatology
|
February 24, 2001
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma
M Kuniyoshi, M Nakamuta, H Sakai, et al.
American Journal of Hematology
|
November 26, 2002
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study
K Tamura, H Matsuoka, J Tsukada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study
T Igarashi, Y Kobayashi, M Ogura, et al.
Bone Marrow Transplantation
|
November 3, 2015
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma
S Fuji, H Fujiwara, N Nakano, et al.
Pathology International
|
March 8, 2002
Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases
Y Yatabe, R Suzuki, Y Matsuno, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
International Journal of Hematology
|
April 4, 2000
Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors
K Takeyama, M Seto, N Uike, et al.
Blood
|
March 25, 2000
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma
Y Yatabe, R Suzuki, K Tobinai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
R Seki, K Ohshima, T Fujisaki, et al.
Leukemia & Lymphoma
|
August 23, 2000
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study Group
K Itoh, T Ohtsu, Y Sasaki, et al.
International Journal of Hematology
|
October 20, 2000
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis
T Okamoto, A Kanamaru, C Shimazaki, et al.
Journal of Gastroenterology and Hepatology
|
February 24, 2001
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma
M Kuniyoshi, M Nakamuta, H Sakai, et al.
American Journal of Hematology
|
November 26, 2002
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study
K Tamura, H Matsuoka, J Tsukada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study
T Igarashi, Y Kobayashi, M Ogura, et al.
Bone Marrow Transplantation
|
November 3, 2015
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma
S Fuji, H Fujiwara, N Nakano, et al.
Pathology International
|
March 8, 2002
Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases
Y Yatabe, R Suzuki, Y Matsuno, et al.
Page
of 7